TREA

79139640 - A

Follow

Information

  • Trademark
  • 79139640
  • Serial Number
    79139640
  • Registration Number
    4619191
  • Filing Date
    October 16, 2013
    11 years ago
  • Registration Date
    October 14, 2014
    10 years ago
  • Transaction Date
    October 14, 2023
    a year ago
  • Status Date
    August 30, 2021
    3 years ago
  • Published for Opposition Date
    July 29, 2014
    10 years ago
  • Location Date
    August 30, 2021
    3 years ago
  • Status Code
    708
  • Employee Name
    LAVACHE, LINDA M
  • Attorney Docket Number
    ASEDASCI-2-T
    Attorney Name
    Jeffery A. Smith
    Law Office Assigned Location Code
    L60
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
A
Case File Statements
  • DM0000: The mark consists of the letter "A" formed by three oblong shapes.
  • GS0091: [ Measuring apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometry analyzers for cellular analysis; scientific, optical, measuring, signaling and checking apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometers for single cell and population based cellular analysis; measuring and testing machines and instruments, namely, protein separation and isolation instruments, flow cytometers, and laboratory liquid handlers and automation for testing and implementing cellular based screening methods; laboratory apparatus and instruments for use in growing, maintaining, evaluating and quality control of cell cultures, automated liquid dispensing, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes; chemistry apparatus and instruments for maintaining, evaluating and quality control of cell cultures, automated liquid dispensing of compound preparations and chemical reagents, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purpose ]
  • GS0051: [ In vitro diagnostic preparations for medical use; diagnostic test reagents for medical use; chemical reagents for medical or veterinary use; diagnostic reagents and contrast media agents for medical use; Medical diagnostic reagents; Reagents for medical use ]
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0421: Scientific research and development; scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing services and protein isolation for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect, and scientific research and development relating thereto; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, [ drug discovery and characterization of compound effect, and protein separation, isolation and characterization; ] scientific research services; scientific testing and analysis in the fields of pharmaceutical research, [ drug discovery and characterization of compound effect, and protein separation, isolation and characterization; ] computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; pharmaceutical research and development; ] Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery [ and characterization of chemical compounds, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research ]; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; [ provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and ] scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]
Case File Event Statements
  • 10/14/2023 - a year ago
    43 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4
  • 9/29/2023 - a year ago
    42 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL
  • 6/7/2023 - a year ago
    41 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN
  • 3/27/2023 - a year ago
    40 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 9/20/2022 - 2 years ago
    39 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP
  • 8/3/2022 - 2 years ago
    38 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INPS
  • 8/3/2022 - 2 years ago
    37 - INVALIDATION PROCESSED Type: INPC
  • 4/30/2022 - 2 years ago
    36 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 8/30/2021 - 3 years ago
    35 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75
  • 8/30/2021 - 3 years ago
    34 - REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75P
  • 8/27/2021 - 3 years ago
    33 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 4/14/2021 - 3 years ago
    32 - TEAS SECTION 71 & 15 RECEIVED Type: ES75
  • 10/14/2019 - 5 years ago
    31 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 4/24/2015 - 9 years ago
    30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 3/11/2015 - 9 years ago
    29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 3/11/2015 - 9 years ago
    28 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 1/14/2015 - 10 years ago
    27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 10/14/2014 - 10 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/31/2014 - 10 years ago
    25 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 7/29/2014 - 10 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/29/2014 - 10 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/24/2014 - 10 years ago
    22 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 7/9/2014 - 10 years ago
    21 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 7/9/2014 - 10 years ago
    20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 7/9/2014 - 10 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/26/2014 - 10 years ago
    18 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 6/25/2014 - 10 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 6/9/2014 - 10 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/9/2014 - 10 years ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/9/2014 - 10 years ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/9/2014 - 10 years ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/9/2014 - 10 years ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/4/2014 - 10 years ago
    11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 3/4/2014 - 10 years ago
    10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/22/2014 - 10 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/6/2014 - 10 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/6/2014 - 10 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/6/2014 - 10 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/5/2014 - 10 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/31/2014 - 10 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/17/2013 - 11 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/13/2013 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/12/2013 - 11 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR